GFP/Luc Reporter Cell Line - ASPC-1

ASPC-1 is a human pancreatic adenocarcinoma cell line established from ascites fluid obtained from a patient with metastatic pancreatic cancer. The cell line is characterized by aggressive growth behavior and metastatic potential, making it one of the most widely used models for studying pancreatic ductal adenocarcinoma (PDAC). ASPC-1 cells harbor genetic alterations commonly observed in pancreatic cancer and have been extensively utilized in investigations of tumor progression, invasion, metastasis, and therapeutic resistance. The GFP/Luc Reporter Cell Line - ASPC-1 is generated through stable integration of green fluorescent protein (GFP) and firefly luciferase (Luc) reporter genes into the parental ASPC-1 cells. This dual-reporter system enables real-time fluorescence visualization and highly sensitive bioluminescence imaging while preserving the biological characteristics and tumorigenic properties of the original cell line.

The ASPC-1-GFP/Luc reporter cell line is widely employed in pancreatic cancer research for both in vitro functional studies and in vivo tumor modeling. Luciferase expression allows non-invasive, longitudinal monitoring of tumor growth, metastatic dissemination, and therapeutic response through bioluminescence imaging in xenograft and orthotopic pancreatic cancer models. GFP expression facilitates direct observation of cell proliferation, migration, invasion, and tissue localization in cultured cells and excised tumor specimens. This model is particularly valuable for evaluating novel chemotherapeutic agents, targeted therapies, immunotherapeutic strategies, and combination treatment approaches aimed at overcoming the intrinsic treatment resistance of pancreatic cancer. In addition, the dual-reporter platform supports mechanistic studies of tumor microenvironment interactions, epithelial–mesenchymal transition, cancer stem cell-associated phenotypes, and signaling pathways involved in pancreatic tumor progression and metastasis. Owing to its stable reporter expression and reproducible imaging performance, the ASPC-1-GFP/Luc cell line provides a robust and reliable tool for preclinical drug screening, therapeutic efficacy assessment, and translational research in pancreatic adenocarcinoma.